Skip to content

Report a Typo or Mistake

Optional

Optional

Optional

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Verify
push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks